Brewin Dolphin LTD Imv Inc. Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2023
SELL
$1.35 - $2.16 $14,175 - $22,680
-10,500 Closed
0 $0
Q3 2018

Nov 09, 2023
BUY
$4.65 - $5.94 $12,499 - $15,966
2,688 Added 34.41%
10,500 $62.4 Million
Q2 2018

Nov 09, 2023
BUY
$4.42 - $7.13 $34,529 - $55,699
7,812 New
7,812 $39.7 Million

About IMV Inc.

IMV Quotes by TradingView
  • Ticker IMV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,452,200
  • Description
  • IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...
More about IMV
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email